Involvement of mitochondrial/lysosomal toxic cross-talk in ecstasy induced liver toxicity under hyperthermic condition

European Journal of Pharmacology

Volumn 643, Issue 2-3, 2010, Pages 162-169

  Pourahmad, Jalal ^a   Eskandari, Mohammad Reza ^a   Nosrati, Masoumeh ^a   Kobarfard, Farzad ^a   Khajeamiri, Ali Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

3, 4 Methylenedioxymethamphetamine; Cytotoxicity; Hepatocyte; Hyperthermia; Mitochondrial lysosomal cross talk; Oxidative stress

Indexed keywords

1 BENZYLIMIDAZOLE; 3 METHYLADENINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 METHYLPYRAZOLE; 4 PHENYLIMIDAZOLE; ALPHA TOCOPHEROL; BUTYLATED HYDROXYANISOLE; BUTYLCRESOL; CARNITINE; CATALASE; CHLOROQUINE; CYCLOSPORIN; DEFEROXAMINE; DIMETHYL SULFOXIDE; DIPHENYLIODONIUM SALT; MANNITOL; METHYLAMINE; MONENSIN; QUINIDINE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRIFLUOPERAZINE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; HIGH TEMPERATURE; LIVER CELL; LIVER TOXICITY; LYSOSOME MEMBRANE; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 77955266647     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.06.019     Document Type: Article

References (38)

1. Alves E., Summavielle T., Alves C.J., Gomes-da-Silva J., Barata J.C., Fernandes E., Bastos M.D.L., Tavares M.A., Carvalho F. Monoamine oxidase-B mediates ecstasy-induced neurotoxic effects to adolescent rat brain mitochondria. J. Neurosci. 2007, 27:10203-10210.
2. Andersson B.S., Aw T.Y., Jones D.P. Mitochondrial transmembrane potential and pH gradient during anoxia. Am. J. Physiol. 1987, 252:C349-C355.
3. Bai F., Lau S.S., Monks T.S. Glutathione and N-acetylcysteine conjugates of α-methyldopamine produce serotoninergic neurotoxicity: possible role in methylenedioxyamphetamine-mediated neurotoxicity. Chem. Res. Toxicol. 1999, 12:1150-1157.
4. Beitia G., Cobreros A., Sainz L., Cenarruzabeitia E. 3, 4-Methylenedioxymethamphetamine (ecstasy)-induced hepatotoxicity: effect on cytosolic calcium signals in isolated hepatocytes. Liver 1999, 19:234-241.
5. Beitia G., Cobreros A., Sainz L., Cenarruzabeitia E. Ecstasy-induced toxicity in rat liver. Liver 2000, 20:8-15.
6. Bolton J.L., Trush M.A., Penning T.M., Dryhurst G., Monks T.J. Role of quinones in toxicology. Chem. Res. Toxicol. 2000, 13:135-160.
7. Brown J.M., Yamamoto Y.B. Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress. Pharmacol. Thera. 2003, 99:45-53.
8. Cadet J.L., Thiriet N., Jayanthi S. Involvement of free radicals in MDMA-induced neurotoxicity in mice. Ann Med Interne (Paris). 2001, 152:57-59.
9. Capela J.P., Macedo C., Branco P.S., Ferreira L.M., Lobo A.M., Fernandes E., Remiao F., Bastos M.L., Dirnagl U., Meisel A., Carvalho F. Neurotoxicity of thioether ecstasy metabolites. Neuroscience 2007, 146:1743-1757.
10. Capela J.P., Carmo H., Remiao F., Bastos M.L., Meisel A., Carvalho F. Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. Mol. Neurobiol. 2009, 39:210-271.
11. Carvalho F., Remiao F., Soares M.E., Catarino R., Queiroz G., Bastos M.L. d-Amphetamine-induced hepatotoxicity: possible contribution of catecholamines and hyperthermia to the effect studied in isolated rat hepatocytes. Arch. Toxicol. 1997, 71:429-436.
12. Crean R.D., Davis S.A., Von Huben S.N., Lay C.C., Katner S.N., Taffe M.A. Effects of (±)3,4methylenedioxymethamphetamine, (±)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques. Neuroscience 2006, 142:515-525.
13. De la Torre R., Farre M. Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans. Trends Pharmacol. Sci. 2004, 25:505-508.
14. De la Torre R., Farre M., Roset P.N., Pizarro N., Abanades S., Segura M., Segura J., Cami J. Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition. Ther. Drug Monit. 2004, 26:137-144.
15. Galati G., Teng S., Moridani M.Y., Chan T.S., O'Brien P.J. Cancer chemoprevention and apoptosis mechanisms induced by dietary polyphenolics. Drug Metabol Drug Interact. 2000, 17:311-349.
16. Green A.R., Mechan A.O., Elliott J.M., O'Shea E., Colado M.I. The pharmacology and clinical pharmacology of 3,4methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol. Rev. 2003, 55:463-508.
17. Green A.R., O'Shea E., Saadat K.S., Elliott J.M., Colado M.I. Studies on the effect of MDMA ("ecstasy") on the body temperature of rats housed at different ambient room temperatures. Br. J. Pharmacol. 2005, 146:306-312.
18. Gudelsky G.A., Yamamoto B.K. Neuropharmacology and neurotoxicity of 3,4-methylenedioxymethamphetamine. Meth. Mol. Med. 2003, 79:55-73.
19. Hall A.P., Henry J.A. Acute toxic effects of 'ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management. Br. J. Anaesth. 2006, 96:678-685.
20. Hiramatsu M., Kumagai Y., Unger S.E., Cho A.K. Metabolism of methylenedioxymethamphetamine: formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct. J. Pharmacol. Exp. Ther. 1990, 254:521-527.
21. Izco M., Orio L., O'shea E., Colado M.I. Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain. Psychopharmacology (Berl.) 2007, 189:459-470.
22. Khan S., O'Brien P.J. 1-Bromoalkanes as new potent nontoxic glutathione depletors in isolated rat hepatocytes. Biochem. Biophys. Res. Commun. 1991, 179:436-441.
23. Kreth K.P., Kovar K.A., Schwab M., Zanger U.M. Identification of the human cytochromes P450 involved in the oxidative metabolism of "ecstasy"-related designer drugs. Biochem. Pharmacol. 2000, 59:1563-1571.
24. Lim H.K., Foltz R.L. In vivo and in vitro metabolism of 3,4-(methylenedioxy)methamphetamine in the rat: identification of metabolites using an ion trap detector. Chem. Res. Toxicol. 1988, 1:370-378.
25. Maurer H.H., Kraemer T., Springer D., Staack R.F. Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrrolidinophenone types: a synopsis. Ther. Drug Monit. 2004, 26:127-131.
26. Meyer M.R., Peters F.T., Maurer H.H. The role of human hepatic cytochrome P450 isozymes in the metabolism of racemic 3,4-methylenedioxy-methamphetamine and its enantiomers. Drug Metab. Dispos. 2008, 36:2345-2354.
27. Montiel-Duarte C., Varela-Rey M., Osés-Prieto J.A., Lopez-Zabalza M.J., Beitia G., Cenarruzabeitia E., Iraburu M.J. 3,4-Methylenedioxymethamphetamine ("ecstasy") induces apoptosis of cultured rat liver cells. Biochim. Biophys. Acta 2002, 1588:26-32.
28. Nakagawa Y., Suzuki T., Tayama S., Ishii H., Ogata A. Cytotoxic effects of 3,4-methylenedioxy-N-alkylamphetamines, MDMA and its analogues, on isolated rat hepatocytes. Arch. Toxicol. 2009, 83:69-80.
29. Piper B.J. A developmental comparison of the neurobehavioral effects of ecstasy (MDMA). Neurotoxicol. Teratol. 2007, 29:288-300.
30. 2+ induced hepatocyte cytotoxicity. Chem. Biol. Interact. 2000, 126:159-169.
31. Pourahmad J., Ghashang M., Ettehadi H., Ghalandari A. A search for cellular and molecular mechanisms involved in depleted uranium toxicity. Environ. Toxicol. 2006, 21:349-354.
32. Pourahmad J., O'Brien P.J., Chan K., Shakouri A. Tetramethylphenylenediamine-induced hepatocyte cytotoxicity caused by lysosomal labilisation and redox cycling with oxygen activation. Chem. Biol. Interact. 2008, 172:39-47.
33. Pourahmad J., Amirmostofian M., Kobarfard F., Shahraki J. Biological reactive intermediates that mediate dacarbazine cytotoxicity. Cancer Chemother. Pharmacol. 2009, 65:89-96.
34. Rezaei M., Rasekh H.R., Ahmadiani A., Pourahmad J. Involvement of subcellular organelles in inflammatory pain-induced oxidative stress and apoptosis in the rat hepatocytes. Arch. Iran. Med. 2008, 11:407-417.
35. Riezzo I., Cerretani D., Fiore C., Bello S., Centini F., D'Errico S., Fiaschi A.I., Giorgi G., Neri M., Pomara C., Turillazzi E., Fineschi V. Enzymatic-nonenzymatic cellular antioxidant defense systems response and immunohistochemical detection of MDMA, VMAT2, HSP70, and apoptosis as biomarkers for MDMA (ecstasy) neurotoxicity. J. Neurosci. Res. 2010, 88:905-916.
36. Skibba J.L., Powers R.H., Stadnicka A., Cullinane D.W., Almagro U.A., Kalbfleisch J.H. Oxidative stress as a precursor to the irreversible hepatocellular injury caused by hyperthermia. Int. J. Hyperthermia 1991, 7:749-761.
37. Von Huben S.N., Lay C.C., Crean R.D., Davis S.A., Katner S.N., Taffe M.A. Impact of ambient temperature on hyperthermia induced by (±)3,4-methylenedioxymethamphetamine in Rhesus Macaques. Neuropsychopharmacology 2007, 32:673-681.
38. Zhou J.F., Zhou Y.H., Zhang L., Chen H.H., Cai D. 3,4-Methylenedioxymethamphetamine (MDMA) abuse markedly inhibits acetylcholinesterase activity and induces severe oxidative damage and liperoxidative damage. Biomed. Environ. Sci. 2003, 16:53-61.